Graded against 173,636 supplements + 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, NIH DSLD
Artemisinin
MODERATE EVIDENCESupplementLast updated
AVELOR SUMMARY
Artemisinin is the anti-malarial compound from sweet wormwood (Artemisia annua) that won the 2015 Nobel Prize for Tu Youyou. In supplement form, used for: (1) malaria prevention/treatment (WHO-approved as ACT therapy); (2) anti-parasitic; (3) anti-cancer (iron-dependent free radical mechanism — cancer cells have 5-15x more transferrin receptors than normal cells). As a supplement: 200-600mg/day in short courses (4 weeks max). Long-term use depletes iron. Artesunate (water-soluble derivative) is preferred for acute treatment. NOT a substitute for pharmaceutical ACT therapy for malaria.
---
*Reviewed by the Dose AI Research Team and Clinical Advisory Board*
*Last updated: 2026-04-06*
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.